IBDEI0R7 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12463,0)
 ;;=E11.8^^74^722^31
 ;;^UTILITY(U,$J,358.3,12463,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12463,1,3,0)
 ;;=3^Diabetes Type 2 w/ Unspec Complications
 ;;^UTILITY(U,$J,358.3,12463,1,4,0)
 ;;=4^E11.8
 ;;^UTILITY(U,$J,358.3,12463,2)
 ;;=^5002665
 ;;^UTILITY(U,$J,358.3,12464,0)
 ;;=N18.6^^74^722^34
 ;;^UTILITY(U,$J,358.3,12464,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12464,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,12464,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,12464,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,12465,0)
 ;;=N18.9^^74^722^17
 ;;^UTILITY(U,$J,358.3,12465,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12465,1,3,0)
 ;;=3^Chr Kidney Disease,Unspec
 ;;^UTILITY(U,$J,358.3,12465,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,12465,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,12466,0)
 ;;=E11.36^^74^722^26
 ;;^UTILITY(U,$J,358.3,12466,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12466,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Cataract
 ;;^UTILITY(U,$J,358.3,12466,1,4,0)
 ;;=4^E11.36
 ;;^UTILITY(U,$J,358.3,12466,2)
 ;;=^5002642
 ;;^UTILITY(U,$J,358.3,12467,0)
 ;;=E11.40^^74^722^27
 ;;^UTILITY(U,$J,358.3,12467,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12467,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Neurpathy,Unspec
 ;;^UTILITY(U,$J,358.3,12467,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,12467,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,12468,0)
 ;;=E11.51^^74^722^28
 ;;^UTILITY(U,$J,358.3,12468,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12468,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Peripheral Angiopath w/o Gangrene
 ;;^UTILITY(U,$J,358.3,12468,1,4,0)
 ;;=4^E11.51
 ;;^UTILITY(U,$J,358.3,12468,2)
 ;;=^5002650
 ;;^UTILITY(U,$J,358.3,12469,0)
 ;;=E29.1^^74^722^77
 ;;^UTILITY(U,$J,358.3,12469,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12469,1,3,0)
 ;;=3^Testicular Hypofunction
 ;;^UTILITY(U,$J,358.3,12469,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,12469,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,12470,0)
 ;;=E04.1^^74^722^78
 ;;^UTILITY(U,$J,358.3,12470,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12470,1,3,0)
 ;;=3^Thyroid Nodule,Single,Nontoxic
 ;;^UTILITY(U,$J,358.3,12470,1,4,0)
 ;;=4^E04.1
 ;;^UTILITY(U,$J,358.3,12470,2)
 ;;=^5002478
 ;;^UTILITY(U,$J,358.3,12471,0)
 ;;=E03.9^^74^722^51
 ;;^UTILITY(U,$J,358.3,12471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12471,1,3,0)
 ;;=3^Hypothyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,12471,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,12471,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,12472,0)
 ;;=M81.0^^74^722^75
 ;;^UTILITY(U,$J,358.3,12472,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12472,1,3,0)
 ;;=3^Osteoporosis,Age-Related w/o Current Path Fracture
 ;;^UTILITY(U,$J,358.3,12472,1,4,0)
 ;;=4^M81.0
 ;;^UTILITY(U,$J,358.3,12472,2)
 ;;=^5013555
 ;;^UTILITY(U,$J,358.3,12473,0)
 ;;=E05.90^^74^722^47
 ;;^UTILITY(U,$J,358.3,12473,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12473,1,3,0)
 ;;=3^Hyperthyroidism w/o Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,12473,1,4,0)
 ;;=4^E05.90
 ;;^UTILITY(U,$J,358.3,12473,2)
 ;;=^5002492
 ;;^UTILITY(U,$J,358.3,12474,0)
 ;;=C73.^^74^722^52
 ;;^UTILITY(U,$J,358.3,12474,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12474,1,3,0)
 ;;=3^Malig Neop Thyroid Gland
 ;;^UTILITY(U,$J,358.3,12474,1,4,0)
 ;;=4^C73.
 ;;^UTILITY(U,$J,358.3,12474,2)
 ;;=^267296
 ;;^UTILITY(U,$J,358.3,12475,0)
 ;;=E04.2^^74^722^37
 ;;^UTILITY(U,$J,358.3,12475,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12475,1,3,0)
 ;;=3^Goiter,Multinodular,Nontoxic
 ;;^UTILITY(U,$J,358.3,12475,1,4,0)
 ;;=4^E04.2
 ;;^UTILITY(U,$J,358.3,12475,2)
 ;;=^267790
 ;;^UTILITY(U,$J,358.3,12476,0)
 ;;=E78.4^^74^722^42
